Source: Stuff.co.nz
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Happy Valley Nutrition (HVM) advises Chief Executive Officer Greg Wood has announced his resignation from the company
  • His resignation is immediate but the former CEO will continue to work with the company to ensure a smooth hand over whilst the company find a suitable replacement
  • The company also thanked Mr Wood, saying he played an integral role in advancing the development of its state-of-the-art nutritional grade facility in New Zealand
  • Happy Valley Nutrition shares are down 6.8 per cent to trade at 5.5 cents

Happy Valley Nutrition (HVM) advises Chief Executive Officer Greg Wood has announced his resignation from the company.

His resignation is immediate but HVM said he would continue to work with the company to ensure a smooth hand whilst Happy Valley find a suitable replacement.

Since listing on the ASX in early 2020, the company said Mr Wood has played an integral role in advancing the development of its state-of-the-art nutritional grade facility in New Zealand.

The company added that it will continue to support the New Zealand management team as it advances financing and offtake agreements which are ongoing with a number of parties.

Happy Valley Nutrition Chairmain Ivan Hammerschalg said the company was grateful for the former CEO’s commitment.

“Over what has been a very challenging two and a half years for many companies given the global pandemic, Greg Wood and his team have delivered critical milestones to the point where we now have a world class, shovel-ready nutritional grade Facility,” he said.

Happy Valley Nutrition shares are down 6.8 per cent to trade at 5.5 cents at 1:26 pm AEDT.

HVM by the numbers
More From The Market Herald

" PointsBet (ASX:PBH) losses extend to $51.8m

PointsBet (ASX:PBH) has reported $51.8 million in cash outflows for its quarterly update as the company…
Imugene (ASX:IMU) - CEO, Leslie Chong

" Imugene (ASX:IMU) signs clinical trial agreement with Roche for lung cancer

Imugene (ASX:IMU) signs a clinical trial supply agreement with Roche to evaluate the combination of treatments…
Fiji Kava (ASZ:FIJ) - CEO and Managing Director, Dr Anthony Noble

" Fiji Kava (ASX:FIJ) hits quarterly revenue record

Fiji Kava (ASX:FIJ) has tabled a record quarterly revenue of $476,531 for the December quarter, up…
Imagion Biosystems (ASX:IBX) - CEO & Executive Chairman, Bob Proulx

" Imagion (ASX:IBX) ends 2021 on an “upbeat note”

Imagion Biosytems (ASX:IBX) finishes 2021 on an "upbeat note" as it progresses with its MagSense HER2…